|
Related to |
StoriesNew AI method tracks immune responses without known antibody databases9.September » THE MEDICAL NEWS A research team comprising Associate Professor FUNAKOSHI Yohei, Associate Professor YAKUSHIJIN Kimikazu, Professor MINAMI Hironobu, and Associate Professor OHJI Goh of Kobe University, together with graduate student MASUDA Genki, then-graduate stude… Is There a Summer COVID Surge? With Cases Rising in Nearly Every State, Watch for These Symptoms4.September » iVillage As summer winds down, COVID-19 cases are growing in at least 45 states. Here’s where COVID is surging and what to know about the vaccine. Antiviral COVID-19 drug shows no benefit for Long COVID1.September » THE MEDICAL NEWS Results from a clinical trial funded by the National Institutes of Health (NIH) and published today in the journal Lancet Infectious Diseases show that the antiviral drug, PAXLOVID, commonly prescribed to treat acute COVID-19, does not have an impac… FDA Approves Four Updated COVID Shots Targeting XFG Variant28.August » MedPageToday (MedPage Today) -- The FDA approved four updated COVID-19 vaccines for the 2026-2027 season targeting the SARS-C0V-2 variant that dominated last season. Moderna, Pfizer and BioNTech, and Novavax, Sanofi, and Takeda announced Thursday that their... Researchers tested dozens of clues for long COVID. One finding stood out28.August » THE MEDICAL NEWS A nationwide study of 218 people in the Faroe Islands examined clinical, neurological, and blood-based markers associated with persistent symptoms around six months after SARS-CoV-2 infection. Despite extensive testing, researchers found no convinci… Nigerian COVID-19 response highlights cultural trust in ethnopharmacology25.August » THE MEDICAL NEWS During COVID-19, ethnopharmacology became prominent in Nigeria due to affordability, accessibility, and cultural trust, but evidence for safety and efficacy remains limited. Shingles vaccine linked to 24% lower dementia risk25.August » ScienceDaily Older adults who received the Shingrix shingles vaccine were 24% less likely to be diagnosed with dementia over four years in a study of more than 500,000 people. Researchers estimate the difference could amount to roughly one dementia case prevente… This yeast supplement may boost cancer-fighting immunity22.August » ScienceDaily A simple yeast-based food supplement may help restore the immune system’s ability to fight cancer, according to new research in mice. Scientists found that yeast beta-glucan reprogrammed early immune cells in the bone marrow, leading to stronger, lo… AI may know how you’ll respond to a vaccine before you get it21.August » ScienceDaily AI may be able to predict how strongly someone will respond to a vaccine before they receive it. By analyzing antibody patterns in more than 4,000 people, researchers found signs of “immune readiness” that helped distinguish strong responders from w… More than 1,000 genetic switches reveal why female immunity is different20.August » ScienceDaily More than 1,000 genetic switches behave differently in male and female immune cells, helping explain why women are much more vulnerable to autoimmune diseases such as lupus. Female immune systems appear genetically tuned for stronger inflammatory re… Novel norovirus vaccine approach may be adaptable for other RNA viruses19.August » THE MEDICAL NEWS Every RNA virus — from stomach bugs and influenza to chickenpox and the common cold — has its own story to tell, with a unique combination of symptoms, rates of transmission, duration, and chemical blueprint. Is There a Summer COVID Surge? With Cases Rising in Every State, Watch for These Symptoms17.August » iVillage As summer winds down, COVID-19 cases are growing in at least 40 states. Here’s where COVID is surging and what to know about the vaccine. |
|